Application and progress of 3D tumor models in breast cancer

被引:0
|
作者
Xu, Jiaojiao [1 ]
Fang, Wanxia [2 ]
Zhou, Huanhuan [1 ]
Jiang, Ruiyuan [3 ]
Chen, Zhanhong [3 ]
Wang, Xiaojia [3 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Dept Colorectal Oncol, Hangzhou, Peoples R China
[3] Zhejiang Canc Hosp, Dept Breast Oncol, Hangzhou, Peoples R China
关键词
breast cancer; in vitro culture; three-dimensional; tumor models; CELLS; MICROENVIRONMENT; HETEROGENEITY; CARCINOMA; PLATFORM; CULTURE; BIOLOGY; 2D;
D O I
10.1002/bit.28860
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Due to its high heterogeneity and significant impact on women's health globally, breast cancer necessitates robust preclinical models to understand tumor biology and guide personalized treatment strategies. Three-dimensional (3D) in vitro tumor models hold immense promise in this regard. These tumor models not only mimic the spatial structure and growth environment of tumors in vivo, but also retain the pathological and genetic characteristics of solid tumors. This fidelity makes them powerful tools for accelerating advancements in fundamental research and translational medicine. The diversity, modularity, and efficacy of 3D tumor models are driving a biotechnological revolution. As these technologies become increasingly sophisticated, 3D tumor models are poised to become powerful weapons in the fight against breast cancer. This article expounds on the progress made in utilizing 3D tumor models for breast cancer research. The progress and application of 3D tumor models in breast cancer are described in this study. In precision and translational medicine, 3D tumor models are crucial tools for weighing the benefits and drawbacks of various model types. Xu and coworkers highlight that the application of 3D tumor models is covertly promoting experimental exploration of breast cancer and improving the survival of breast cancer patients.image
引用
收藏
页码:30 / 43
页数:14
相关论文
共 50 条
  • [1] 3D Breast Tumor Models for Radiobiology Applications
    Ravichandran, Akhilandeshwari
    Clegg, Julien
    Adams, Mark N.
    Hampson, Madison
    Fielding, Andrew
    Bray, Laura J.
    CANCERS, 2021, 13 (22)
  • [2] 3D Tumor Models for Breast Cancer: Whither We Are and What We Need
    Balachander, Gowri Manohari
    Kotcherlakota, Rajesh
    Nayak, Biswadeep
    Kedaria, Dhaval
    Rangarajan, Annapoorni
    Chatterjee, Kaushik
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2021, 7 (08) : 3470 - 3486
  • [3] The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
    Froehlich, Eleonore
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [4] 3D Bioprinting of Tumor Models for Cancer Research
    Kang, Youngnam
    Datta, Pallab
    Shanmughapriya, Santhanam
    Ozbolat, Ibrahim T.
    ACS APPLIED BIO MATERIALS, 2020, 3 (09) : 5552 - 5573
  • [5] Hypoxia suppresses radiation-induced tumor immunogenicity in 3D breast cancer models
    Gruber, S.
    Charpentier, M.
    Wennerberg, E.
    Van Nest, S.
    Demaria, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S314 - S314
  • [6] Curcumin nanoparticles combined with 3D printed bionic tumor models for breast cancer treatment
    Su, Ya
    Hu, Xueyan
    Kang, Yue
    Zhang, Cheng
    Cheng, Yuen Yee
    Jiao, Zeren
    Nie, Yi
    Song, Kedong
    BIOFABRICATION, 2023, 15 (01)
  • [7] 3D Breast Models
    Nishikawa, R.
    Glick, S.
    Bakic, P.
    Reiser, I.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [8] Diversity Models and Applications of 3D Breast Tumor-on-a-Chip
    Song, Kena
    Zu, Xiangyang
    Du, Zhe
    Hu, Zhigang
    Wang, Jingjing
    Li, Jinghua
    MICROMACHINES, 2021, 12 (07)
  • [9] Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment
    Watters, Karen M.
    Bajwa, Preety
    Kenny, Hilary A.
    CANCERS, 2018, 10 (08)
  • [10] Current and Emerging 3D Models to Study Breast Cancer
    Roberts, Sophie
    Peyman, Sally
    Speirs, Valerie
    BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 413 - 427